Diet-driven approach to ease constipation in people with Parkinson’s
Official title: Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease: A Randomized Clinical Trial
Run by Hospital de Clinicas de Porto Alegre · NCT07213856 · Data updated 2026-11-12
A dietitian-guided nutritional plan is tested to see if it increases weekly bowel movements and improves gut health in adults with Parkinson’s disease and functional constipation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | Hospital de Clinicas de Porto Alegre Academic / other |
| Locations | 1 site (Porto Alegre, Rio Grande do Sul) |
| Status | Recruiting |
| Started | April 2, 2026 |
| Main results expected | June 2027 |
| Study ends | August 2029 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT07213856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson’s disease on a stable levodopa dose and a functional constipation diagnosis.
✕Probably not a fit
People with other underlying conditions or those not adherent to the diet plan may not experience benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether a dietitian-guided nutrition program can help people with Parkinson’s disease who have functional constipation. Participants follow a tailored diet plan designed around dietary reference intakes for three months, with periodic dietitian follow-ups and assessments at baseline, mid-point, and end. The study compares this targeted intervention to general dietary guidance given after the study period to determine effects on bowel function, gut microbiota, dietary intake, and nutritional status. Eligible participants are adults with Parkinson’s disease on stable levodopa therapy and a Rome IV-confirmed constipation diagnosis, while several medical conditions and recent antibiotic or laxative use exclude participation.
Why it matters
Potential benefit: If successful, participants may experience more regular bowel movements and improved gut health.
How similar studies have gone: Previous nutrition-focused studies in similar populations have shown potential benefits for bowel function, but results vary by individual and diet strategy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with a previous diagnosis of Parkinson's disease * On a stable dose of levodopa for at least 3 months * Diagnosis of Functional Constipation by the Rome IV protocol Exclusion Criteria: * Diagnosis of atypical or secondary parkinsonism * Hoehn and Yahr stage greater than 2 * Presence of severe neurological or psychiatric disorders that impair the ability to participate in study procedures * Previous diagnosis of dementia * Presence of comorbidities such as active cancer, chronic obstructive pulmonary disease (COPD), heart failure, and/or chronic kidney disease * History of gastrointestinal cancers, inflammatory bowel diseases, or surgeries involving the gastrointestinal tract * Constipation secondary to clinical conditions such as hypothyroidism or diabetes mellitus * Use of opioids * Use of probiotics or antibiotics in the past 8 weeks * Continuous use of laxatives in the past 8 weeks * Presence of severe dysphagia according to the Functional Oral Intake Scale (FOIS) * Individuals receiving enteral or parenteral nutrition * Individuals under nutritional follow-up in the past 3 months
Where it's running
-
Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, Brazil Recruiting
Study contacts
- Principal investigator: Maira Rozenfeld Olchik, PhD — Federal University of Rio Grande do Sul
- Study coordinator: Maira Rozenfeld Olchik, PhD
- Email: molchik@hcpa.edu.br
- Phone: +55 (51) 33083020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
-
Imaging PD progression with [18F]AV-133 using high- and standard-resolution PET
This study tests how [18F]AV-133 PET imaging changes over 12 months in people with Parkinson's disease and a small group of healthy controls.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Sleep and adaptive DBS in Parkinson’s disease
This study tests whether adjusting adaptive deep brain stimulation during sleep can improve sleep quality and brain activity in people with Parkinson’s disease who already have DBS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.